Posts

Artificial Intelligence in Drug Repurposing Market Trends Pharma Can't Ignore

The global artificial intelligence in drug repurposing market stood at USD 1.3 billion in 2025 and is forecast to climb to USD 7.7 billion by 2033, growing at a CAGR of 24.5% between 2026 and 2033. North America leads with 52.9% share, oncology is the top application at 36.7%, and software & platform tools account for 66.6% of spend. Baricitinib was designed as a rheumatoid arthritis drug. Within months of the COVID-19 outbreak, BenevolentAI's platform flagged it as a candidate for the virus, and by late 2020 it had emergency FDA authorization for exactly that use. That single case did more to legitimize AI-driven drug repurposing than a decade of academic papers — it proved a known, already-safety-tested compound could be redeployed against a brand-new disease in months, not years. That proof point is now the engine behind a market moving at nearly 25% annual growth. What Is Driving Growth in This Market? Traditional drug discovery is simply too slow and too expensive to ...

AI In Oncology Market Size, Share, and the Story Behind the Numbers

Cancer diagnosis used to hinge almost entirely on the trained eye of a radiologist or pathologist, working scan by scan, slide by slide. That model is now being layered — not replaced, but sharpened — by algorithms that can flag a suspicious lesion in milliseconds or predict a chemotherapy dose from a CT scan's fat, bone, and muscle composition. That shift is exactly what's fueling the AI in oncology market , valued at USD 6.0 billion in 2025 and on track to hit USD 38.9 billion by 2033, expanding at a CAGR of 24.8% from 2026 onward. Numbers this steep usually signal one of two things: a speculative bubble, or a genuine infrastructure shift in how an entire discipline operates. Cancer AI looks far closer to the second. Every major driver behind this growth — rising cancer incidence, FDA clearances crossing the 690-device mark, precision-medicine adoption — points to a field embedding AI into its clinical backbone rather than experimenting at the margins. What's...

Computational Pathology Market Is Creating a New Intelligence Layer for Healthcare

Pathology is moving beyond the microscope. As whole-slide imaging, artificial intelligence (AI), machine learning (ML), computer vision, and advanced analytics become embedded in diagnostic workflows, pathology is evolving into a data-driven discipline where tissue images can be converted into measurable, searchable, and clinically useful information. The global computational pathology market was valued at USD 728.7 million in 2025 and is estimated to reach USD 781.5 million in 2026. By 2033, revenue is projected to reach approximately USD 1.45 billion, representing a 9.2% CAGR from 2026 to 2033. North America currently leads the global revenue mix, while Asia Pacific is positioned as the fastest-growing region. What makes this growth particularly important is that computational pathology is not simply digitizing slides. It is creating a layer of intelligence on top of pathology data—helping clinicians identify patterns, quantify biomarkers, standardize interpretation, and supp...

Wearable AI Market: Consumer Tech Meets Clinical-Grade Precision

The global wearable AI market was worth USD 43.6 billion in 2025 and is on track to reach USD 56.6 billion in 2026, climbing to USD 310.6 billion by 2033 — a CAGR of 27.8%. Asia Pacific leads regionally with a 32.8% revenue share, smart earwear is the top-selling product category at 50% share, and on-device processing (not cloud AI) already handles the majority of workloads. What makes this market unusual isn't the growth rate itself — plenty of tech categories post big numbers early on — it's that the growth is being pulled simultaneously by consumer lifestyle spending and clinical healthcare budgets, two demand pools that rarely move in sync this cleanly. Product Breakdown: Why Earbuds, Not Watches, Lead the Category Ask most people to picture "wearable AI" and they'll describe a smartwatch. The data says otherwise. Smart earwear holds the largest product share at 50% — a full half of category revenue — and the reason is functional, not fashionable. E...

Breast Pump Market: Why Hands-Free Devices Are Becoming the Next Big Growth Engine

The global breast pump market is valued at approximately USD 1.8 billion in 2026 and is projected to reach USD 2.9 billion by 2033, expanding at a CAGR of 7.5%. North America currently leads with over half of global revenue, while Asia Pacific is set to grow the fastest through 2033. Behind these numbers is a quieter story: breast pumps have shifted from a clinical accessory to a lifestyle device, and that shift is what's actually reshaping where the money in this market is going. What Is Fueling Breast Pump Market Growth? Three forces are doing most of the work here, and they compound rather than operate in isolation. Women re-entering and staying in the workforce is the single biggest lever. When female labor participation rises in a country, breast pump demand rises with it on a short lag — not years later, but within one to two budget cycles, because pumping is a workplace-compatibility purchase, not a discretionary one. India's female labor force participation rate cl...

Pressure Sensitive Tapes Market: Packaging Still Leads, but Specialty Tapes Are Stealing the Spotlight

The global pressure sensitive tapes market was valued at USD 74.5 billion in 2025 and is on track to hit USD 110.6 billion by 2033, expanding at a CAGR of 5.1% between 2026 and 2033. Growth is anchored by three forces — e-commerce-driven packaging demand, lightweighting in electric vehicles, and adhesive-chemistry innovation — with Asia Pacific holding the largest regional share at 43.3%. A pressure sensitive tape forms an instant bond under light pressure, with no water, solvent, or heat needed to activate it. That single mechanical property is why the category has quietly become load-bearing infrastructure for four unrelated industries at once: a shipping carton in Ohio, a car door in Wolfsburg, a smartphone in Shenzhen, and a surgical dressing in Mumbai can all depend on the same underlying adhesive science. Understanding where the market is concentrated — by product, by geography, and by company — explains not just what these tapes are worth today, but whic...

Digital Signage Market 2033: The 8.2% Number Behind the Screens

Valued at USD 31.1 billion in 2025, the digital signage market is projected to hit USD 33.6 billion in 2026 and USD 58.4 billion by 2033 — an 8.2% CAGR. North America holds the largest regional share (35.6%), video walls lead by type (25.5%), hardware dominates by component, and Asia Pacific is growing fastest of all regions. The number worth sitting with isn't the CAGR — it's that digital signage is growing roughly twice as fast as general display-technology spending, in a market that was supposedly "mature" a decade ago. The reason is structural: screens have stopped being a marketing expense and started being infrastructure. The sections below answer the questions that explain why. Why Is the Digital Signage Market Growing Faster Than Expected? Because its buyer base has quietly expanded beyond marketing departments. A decade ago, digital signage budgets sat almost entirely inside retail and advertising. Today, hospitals, transit authorities, universities, and ...